Nicole A. Mortier

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Russell E. Ware, Barry R. Davis, William H. Schultz et al. · The Lancet · 2015 · 514 citations · Full text

Medicine, Hematology, Pediatrics +12

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease

Sherri A. Zimmerman, William H. Schultz, Jacqueline S. Davis et al. · Blood · 2003 · 319 citations · Full text

Medicine, Hematology, Pediatrics +12

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia

Sherri A. Zimmerman, William H. Schultz, Shelly Burgett et al. · Blood · 2007 · 219 citations

Medicine, Pediatrics, Pharmacotherapy +7

Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy

Russell E. Ware, Sherri A. Zimmerman, Pamela B. Sylvestre et al. · The Journal of Pediatrics · 2004 · 173 citations

Medicine, Hematology, Pediatrics +16

Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia

Russell E. Ware, Jenny M. Despotovic, Nicole A. Mortier et al. · Blood · 2011 · 168 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12